Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Titan Medical Inc.
Fiscal year is January-December. All values CAD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 24,200 41,419 1.24M 131,968 107,827
COGS excluding D&A 0 0 1.14M 0 0
Depreciation & Amortization Expense 24,200 41,419 97,689 131,968 107,827
Depreciation 0 - 73,445 109,892 104,981
Amortization of Intangibles 24,200 - 24,244 22,076 2,846
Gross Income (24,200) (41,419) (1.24M) (131,968) (107,827)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 752,564 3.68M 14.98M 7.71M 9.28M
Research & Development 166,249 1.57M 12.74M 4.64M 5.69M
Other SG&A 586,315 2.11M 2.24M 3.07M 3.58M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 200,396
EBIT after Unusual Expense 0 0 0 0 (200,396)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income 29,486 33,807 95,067 86,804 62,993
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 0 0 0 0 0
Gross Interest Expense 0 0 0 0 0
Interest Capitalized 0 0 0 0 0
Pretax Income (747,278) (3.69M) (16.13M) (7.76M) (9.52M)
Income Tax 0 0 0 0 (178,969)
Income Tax - Current Domestic 0 0 0 0 0
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic 0 0 0 0 0
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 178,969
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (747,278) (3.69M) (16.13M) (7.76M) (9.34M)
Minority Interest Expense 0 0 0 0 0
Net Income (747,278) (3.69M) (16.13M) (7.76M) (9.34M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (747,278) (3.69M) (16.13M) (7.76M) (9.34M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (747,278) (3.69M) (16.13M) (7.76M) (9.34M)
EPS (Basic) (0.02) (0.09) (0.30) (0.12) (0.13)
Basic Shares Outstanding 33.44M 42.9M 54.29M 64.07M 70.3M
EPS (Diluted) (0.02) (0.09) (0.30) (0.12) (0.13)
Diluted Shares Outstanding 33.44M 42.9M 54.29M 64.07M 70.3M
EBITDA (752,564) (3.68M) (16.12M) (7.71M) (9.28M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.